Skip to main content
. 2018 Jan 25;13:525–536. doi: 10.2147/IJN.S149532

Figure 7.

Figure 7

In vivo antitumor activity of psi-hBCL2/AEMA-g-WSC complexes. (A) Distribution of tumor volumes after injection of psi-hBCL2/WSC at a 1:64 w/w ratio or psi-hBCL2/AEMA-g-WSC at a 1:8 w/w ratio. (B) H&E histological analysis of harvested tumors (×200): (a) control, (b) psi-hBCL2/WSC, (c) psi-hBCL2/AEMA-g-WSC. (C) Immunohistochemical analysis of harvested tumors with anti-BCL2 and anti-caspase-3 monoclonal antibodies: (a) control, (b) psi-hBCL2/WSC, (c) psi-hBCL2/AEMA-g-WSC.

Abbreviation: AEMA-g-WSC, 2-aminoethyl methacrylate-grafted water-soluble chitosan.